Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients

Effect of high-dose intravenous vitamin C on inflammation in cancer patients

(2012) Nina Mikirova et al.   Journal of Translational Medicine

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer

(2011) Michael Graham Espey et al.   FREE RADICAL BIOLOGY AND MEDICINE

Ascorbate exerts anti-proliferative effects through cell cycle inhibition and sensitizes tumor cells towards cytostatic drugs

(2010) Anja Frömberg et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer

(2010) J. Du et al.   CLINICAL CANCER RESEARCH

Inflammation and Cancer: Causes and Consequences

(2010) M M Moore et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Lipid Peroxidation and Antioxidant Status in Head and Neck Squamous Cell Carcinoma Patients

(2010) Aashita Gupta et al.   Oxidative Medicine and Cellular Longevity

Associations Between C-Reactive Protein and Benign Prostatic Hyperplasia/Lower Urinary Tract Symptom Outcomes in a Population-based Cohort

(2009) J. L. St. Sauver et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Systemic inflammation, nutritional status and survival in patients with cancer

(2009) Donald C McMillan   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

Pharmacologic concentrations of ascorbate are achieved by parenteral administration and exhibit antitumoral effects

(2009) Julien Verrax et al.   FREE RADICAL BIOLOGY AND MEDICINE

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer

(2009) Campbell SD Roxburgh et al.   Future Oncology

High dose concentration administration of ascorbic acid inhibits tumor growth in BALB/C mice implanted with sarcoma 180 cancer cells via the restriction of angiogenesis

(2009) Chang-Hwan Yeom et al.   Journal of Translational Medicine

Impact of antioxidant supplementation on chemotherapeutic toxicity: A systematic review of the evidence from randomized controlled trials

(2008) Keith I. Block et al.   INTERNATIONAL JOURNAL OF CANCER

Anti-angiogenic effect of high doses of ascorbic acid

(2008) Nina A Mikirova et al.   Journal of Translational Medicine

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice

(2008) Q. Chen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort

(2007) C. Marsik et al.   CLINICAL CHEMISTRY